Clinical trial of a herbal drug for improving breathing in asthma patients.

Phase 2 clinical trial for assessment of safety and efficacy of a multi component botanical therapeutic (SKBOM) as bronchodilator in patients suffering from asthma.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010435

Enrollment

150

Registered

2017-11-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from asthma and feeling shortness of breath

Interventions

Intervention1: SKBOM: Keep 100-200 mgs of SKBOM on tongue and allow to dissolve slowly in oral cavity. Repeat this whensoever there is feeling of shortness of breath. Control Intervention1: No compara

Eligibility

Inclusion criteria

Inclusion criteria: Patients feeling shortness of breath.

Exclusion criteria

Exclusion criteria: Patients not feeling shortness of breath.

Design outcomes

Primary

Measure	Time frame
Bronchodilation Improvement in feeling of shortness of breath Feeling no shortness of breathTimepoint: 15 Minutes	—

Secondary

Measure	Time frame
Bronchodilation Improvement in feeling of shortness of breath Feeling no shortness of breathTimepoint: 5 Hours	—

Countries

India

Contacts

Public ContactAshok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026